Clinical Trials
3 trialsNCT06459180 2026-05-27
TroFuse-020
Merck Sharp & Dohme LLC
Phase 3 Active not recruiting
NCT03786081 2026-04-14
Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer
Seagen Inc.
Phase 1/2 Terminated
NCT04697628 2026-02-24
innovaTV 301
Seagen Inc.
Phase 3 Completed